Stock has lost 75% of it's value on huge volume that's getting bigger every day and you really believe that the the bad news isn't already in the hands of the hedgies and others?
If yes, you'll be happy to learn Bernie Madoff is opening a new fund. You wouldnt want to miss getting in on the ground floor.
Read a piece that implied Tableaus' poor results triggered this bloodbath in security companies and that Linked In's problems contributed to the problem as jobs for people in security have lessened.
The relatively good news for Vasco is their customer base isn't the larger commercial but rather the banking industry.. The bad news is the banks have their own set of problems and probably aren't putting security at the top of their priority list..
While someone here just pointed out they presumably have enough cash to get them thru 2017, the thing to be fearful of and the reason the stock continues to trade down is precisely that!
Sometime before 2018 they'll have to raise a boatload of money to get them to an endpoint on anything in the pipeline. That'll require another stock offering and that offering will for all practical purposes be so dilutive as to virtually wipe out today's stockholders.
CLDX may not go bankrupt, but todays stockholders will see the value of their stock to to pennies via financing's. The strategy would be to take your $3 today, put it under your mattress until after the next offering and if you believe in their pipeline buy back in on what'll be something like a 90% discount to todays value.
The sensible thing to do would be for them to sell the pipeline and liquidate the company today and distribute the cash to the stockholders. But that would mean no more fat paychecks, so scratch that one from the list.
Celldex is a heap of dog dung and Marucci and company act more like used car salesmen than executives, but things like what happened here are regular events on Wall St.
All the SEC has to do is go back and look at who the big sellers were during the crash and connect a few dots. Someone(s) leaked the rejection well in advance and all you have to do is follow the money and put some feet to the fire. It'd be like shooting fish in a barrel, but they don't. Instead they go after a Martha Stewart type to get the news coverage over what amounted to peanuts.
After watching CYBR and lots of others that that had good qtrs but hinted at a little forward weakness, it'll take a miracle.
Vasco's clients are heavily in the European banking sector which is on it's #$%$, and then we have the loss of the Rabo deal from last year and the drag of the acquisition. I suppose a lot of this is built in as it's no secret, so maybe miracles do happen.
This morning's bump appears to be some nervous small shorts covering.
Stock is what 60% off it's high, trailing PE in the lower teens and forward low 20's maybe. And there's still 30+% short and they're looking to borrow more.
Must be nice to have the inside track.
It was a 100 yard dash. 10 seconds or so. Back to normal already with lots of big sells.
Move the decimal point one more digit to the left and you'll have the stock price by March or April.
About that 90% theory. Be honest, I bet you said the same thing at 50% 60, 70 and 80%. These things do go to zero you know. Happens almost daily.
It's at this price for a reason and history would dictate when they fall this fast this quickly, they are odds on favorites to reach zero. If you haven't read the news their science has been declared junk by independent examiners...and they agreed!
That's true on a global basis, but the only things that are going to move the needle north with this company is a big unanticipated win, or some signs of life related to the acquisition.
And where these guys have traditionally ( or at least lately) have been pretty accurate on their guidance, absent a surprise 2016 is pretty much business as usual. Dead money.
I should have been clearer "retired lady". Medical providers have been under more and more pressure from government for years with increased paperwork ( Hippa for instance), and pricing pressure from medicare medicaid. Since Obamacare, the number of people on medicaid has swelled and their reimbursement rates are lower than Medicares in areas where they can dictate their "allowed" charge.
The point I'm making is Sanders and Clinton have vowed to get medical costs "under control" and I believe they'll go after all providers, including medical devices. Congress may block them temporarily, but another 8 years with either in the white house will be another camel's nose under the tent.
Editorially, if you see what medicare pays for services now compared to "retail" it's dramatic and I'm not certain if it's the retail that's crazy high or the discount ( probably a combination). The sin is if you're uninsured and have resources the hospitals will chase you to your grave to collect the retail. If a clothing retailer puts a crazy high retail on an item and "discounts" it 80% they get fined. The same rules for medical providers would be fair.
I apologize for digressing, but my point remains that I believe any provider of product or services will probably see their pricing limited over time.
Not much of a squeeze, but pretty clear there's some hugging going on. "Appears" there's some nervousness in the short camp. Didn't think anything positive would come from the quarterly results, but it appears the words may be outdistancing the numbers.
If you think the government ( Hillary) won't control pricing, ask a hospital administrator.........especially after Obamacare kicked in.
Taxes I know about, and it does the providers no good to inflate retail for tax purposes. I think the inflated retail numbers are a product of insurers and the governments paying a % of the "ordinary" charge. Inflate the ordinary and get a bigger reimbursement. I know on government grants this is how they work on overhead reimbursements and I personally worked on organizations calculations of their overhead rates to maximize them for this purpose.
How do you end 15 with the biggest backlog ever and an acquisition presumably adding some revenue to the to line and guide so low.
The big Rabo deal skewed the numbers between years, but $205 to $215. That's what they ended 2014 with
Or he's lying about the backlog. I tend to agree with you he's low balling the top line forecast as a buffer. You'd think one of the genius "analysts" would have asked about that in the CC. Who am I kidding, these clowns don't have a clue. Thanks
VDSI will unquestionably reduce guidance for 2016. The question then becomes by how much and how will the price react. That 10 PE is a goner, what will the market decide is the right one.
CYBR's stock price last year didn't belong as high as it was, but this drubbing appears to be way overdone based on what's actually positive guidance that most companies would kill for!